Bone markers in polycystic ovary syndrome: A multi-centre study
Clinical Endocrinology Aug 31, 2017
Lingaiah S, et al. – In this study, researchers examined the serum concentrations of bone turnover (BTMs) and 25–hydroxyvitamin D (25OHD) in women with polycystic ovary syndrome (PCOS) and determined their possible correlations with metabolic parameters of PCOS. It has been shown that bone formation markers were decreased in younger women with PCOS when compared with healthy women, which may affect bone mass in these women.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries